Health plans need a proven partner with the scale and commitment to help achieve their growth goals. Our experts provide innovative, strategic solutions that align with each plans’ unique business priorities in commercial and regulated markets.
Committed to Helping Health Plans Grow

Discover how a partnership built on a foundation of trust and collaboration helps develop an innovative and strategic roadmap that can inform your organization’s future.
Delivering value for those you serve

Commercial
We help you grow and retain your commercial carve-in business, uncovering opportunities to position pharmacy as an affordability lever to drive revenue. By combining prescriber and patient-behavior analytics with drug and network data, we apply actionable insights that improve predictability and health outcomes.
Medicaid
Our flexible Medicaid service model helps to keep you compliant with federal and state regulations; optimize your plan financials; and improve clinical and HEDIS quality outcomes for your members. We understand both the nuances of your market and regulatory challenges, and your need for high-touch support.
Medicare
Regulations and market dynamics that are constantly in flux demand an agile partner to help you grow, win and lead in regulated markets. You can rely on our team of Medicare market strategists to provide you with actionable insights to help improve Star Ratings, achieve quality measures, drive greater affordability and ensure compliance.
Health Insurance Exchanges
In an unpredictable marketplace, exchange members need the right tools at the right time to actively participate in their own health care. Our toolbox includes formulary support; benefit compliance; regulatory support; and market development strategies to help complement your overall objectives in this market.
Work with a partner who offers the guidance and support necessary to help deliver improvements in quality outcomes and Star ratings.
of Medicare beneficiaries we serve are in 4-Star or better plans
of the Medicaid plans we support had a negative drug trend in 2019